JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Scope & Guideline
Pioneering studies that shape the future of heart health.
Introduction
Aims and Scopes
- Molecular Mechanisms in Cardiac Function:
Research on the molecular pathways that regulate cardiac function, including signaling cascades, gene expression, and metabolic processes that influence heart health. - Cardiovascular Disease Mechanisms:
Studies exploring the pathophysiology of various cardiovascular diseases such as heart failure, arrhythmias, and cardiomyopathies, emphasizing the cellular and molecular alterations involved. - Innovative Therapeutic Strategies:
Development and evaluation of novel therapeutic approaches, including gene therapy, stem cell therapy, and pharmacological interventions aimed at repairing or regenerating cardiac tissue. - Cardiac Regeneration and Repair:
Research focused on the mechanisms underlying cardiac regeneration, including the role of stem cells, extracellular matrix, and signaling pathways in promoting tissue repair. - Sex Differences in Cardiovascular Health:
Investigation of how biological sex influences cardiovascular health, disease prevalence, and treatment response, with a focus on molecular and cellular differences. - Integrative Omics Approaches:
Utilization of multi-omics technologies (genomics, proteomics, metabolomics) to provide comprehensive insights into cardiovascular biology and disease mechanisms.
Trending and Emerging
- Cardiovascular Metabolism:
An increasing focus on the role of metabolic pathways in cardiac health and disease, particularly how metabolic dysregulation contributes to conditions such as obesity, diabetes, and heart failure. - Gene Editing and Gene Therapy:
A surge in research utilizing CRISPR and other gene editing technologies to explore genetic underpinnings of cardiovascular diseases and develop targeted gene therapies. - Extracellular Vesicles and Cell Communication:
Emerging studies investigating the role of extracellular vesicles in intercellular communication and their potential as biomarkers or therapeutic agents in cardiovascular diseases. - Inflammation and Immunology in Cardiology:
Growing interest in understanding the immune response in cardiovascular diseases, particularly how inflammation contributes to disease progression and the potential for immunomodulatory therapies. - Single-Cell and Multi-Omics Approaches:
The adoption of single-cell sequencing and integrative multi-omics approaches is on the rise, allowing for a more detailed understanding of cellular heterogeneity and the molecular landscape of cardiovascular diseases. - Personalized Medicine and Cardiovascular Health:
A trend towards personalized approaches to cardiovascular disease management, incorporating genetic, molecular, and clinical data to tailor treatments to individual patients.
Declining or Waning
- Traditional Pharmacology:
There is a noticeable reduction in studies centered on traditional pharmacological approaches to treating heart disease, as the field shifts towards more innovative and targeted therapeutic strategies. - Basic Animal Models:
Research using basic animal models without advanced genetic manipulations or disease modeling techniques has decreased, reflecting a broader trend towards more sophisticated and translational modeling approaches. - Cardiac Imaging Techniques:
While imaging remains a crucial tool in cardiology, there is less emphasis on traditional imaging studies (e.g., echocardiography) in favor of molecular and cellular investigations that provide deeper mechanistic insights. - Aging Research in Cardiovascular Disease:
Although aging is a critical factor in cardiovascular health, publications specifically addressing aging-related mechanisms in a standalone manner have diminished, likely due to a shift towards integrated approaches that consider aging as a variable within broader studies.
Similar Journals
World Journal of Cardiology
Innovating heart health through impactful research and collaboration.World Journal of Cardiology, published by BAISHIDENG PUBLISHING GROUP INC, stands out as a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1949-8462, this journal serves a global audience, promoting knowledge dissemination and collaboration among researchers, healthcare professionals, and students dedicated to advancing cardiovascular health. The journal demonstrates its credibility and impact in the field by achieving a respectable Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine. Notably, it is listed in the Scopus database, ranking #189 out of 387 journals, placing it in the 51st percentile, which underscores its relevance and contribution to contemporary cardiovascular research. Although it operates under a subscription model, the journal provides diverse access options, ensuring that critical findings reach a wide audience. Through its comprehensive scope and commitment to publishing high-quality articles, the World Journal of Cardiology plays a vital role in shaping the future of cardiovascular science, making it an invaluable asset for those involved in this essential discipline.
BIOSCIENCE REPORTS
Fostering Innovation in Biological ResearchBIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.
International Heart Journal
Connecting Researchers to Enhance Cardiovascular CareInternational Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.
Nepalese Heart Journal
Transforming Heart Health Through ResearchNepalese Heart Journal, published by the CARDIAC SOC NEPAL, serves as a premier platform for disseminating knowledge in the field of cardiology and cardiovascular health. With an ISSN of 2091-2978, this journal aims to bridge the gap between researchers, clinicians, and academicians by presenting high-quality, peer-reviewed articles that address clinical practices, innovative research, and emerging trends in heart disease management, especially within the context of Nepal and the surrounding region. Although it operates under a traditional publishing model, its commitment to excellence aids in reinforcing the scientific discourse in an area critical to public health. The journal is a valuable resource for professionals and students alike who are focused on advancing their understanding of cardiology and its implications for health policy and practice. Exploring the intersections of local challenges and global advancements in heart health, the Nepalese Heart Journal is poised to contribute meaningfully to the evolving landscape of cardiovascular research.
ACTA CARDIOLOGICA
Exploring the forefront of cardiac research.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
Nature Cardiovascular Research
Pioneering insights into the heart of cardiovascular science.Nature Cardiovascular Research, published by SpringerNature in Germany, stands as a premier journal dedicated to advancing the field of cardiovascular sciences. With an impressive 2023 categorization in the Q1 quartile across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, Cardiology, and Medicine—this journal uniquely positions itself as a leading resource for pioneering research and innovative findings. Although currently not open access, it provides a rich repository of peer-reviewed articles that contribute directly to the evolving landscape of cardiovascular medicine. The journal aims to bridge the knowledge gap between basic science and clinical application, catering to researchers, healthcare professionals, and students alike who are immersed in the complexities of cardiovascular health. With robust Scopus rankings in key categories, Nature Cardiovascular Research is poised to shape future directions in the field, helping to foster a deeper understanding of cardiovascular diseases and their underlying mechanisms. Explore the latest research and be part of the conversation in one of the most impactful scientific domains.
CELLULAR SIGNALLING
Illuminating Pathways in Biochemistry and GeneticsCELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.
Journal of Cardiovascular Development and Disease
Advancing cardiovascular knowledge for a healthier tomorrow.Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
Empowering Discoveries in Molecular BiologyCellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.
Current Opinion in Physiology
Uncovering Innovative Perspectives in PhysiologyCurrent Opinion in Physiology, published by Elsevier, is a leading journal dedicated to the dynamic field of physiology. With an E-ISSN of 2468-8673, this journal provides a platform for the latest insights and perspectives, reflecting the evolving landscape of physiological research. Operating from the United Kingdom, the journal holds a respectable impact factor and is ranked Q2 in both general physiology and medical physiology categories, highlighting its prominence among the global academic community. With Scopus rankings placing it in the 64th and 60th percentiles within its respective categories, Current Opinion in Physiology serves as an essential resource for researchers, professionals, and students eager to stay informed about innovative theories and emerging trends in physiology. The publication emphasizes high-quality reviews that summarize current knowledge and future directions, ensuring readers gain valuable insights applicable in both clinical and research settings.